Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser

Dermatologic Surgery

Volumn 30, Issue 9, 2004, Pages 1201-1204

  Alster, Tina S ^a   Gupta, Samir N ^b  

^a WASHINGTON INSTITUTE OF DERMATOLOGIC LASER SURGERY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DESQUAMATION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPIGMENTATION; LASER; MALE; PIGMENT DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PURPURA; Q SWITCHED ALEXANDRITE LASER; RISK ASSESSMENT; SAFETY; SCAR FORMATION; SIDE EFFECT; SKIN PIGMENTATION; TECHNOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; BERYLLIUM; FEMALE; HUMANS; HYPERPIGMENTATION; LASERS; MALE; MIDDLE AGED; MINOCYCLINE;

EID: 4744359630     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30372.x     Document Type: Article

References (33)

1. Basler RSW. Minocycline therapy for acne. Arch Dermatol 1979;115:1391.
2. McGrae JD Jr, Zelickson AS. Skin pigmentation secondary to minocycline therapy. Arch Dermatol 1980;116:1262-5.
3. Ridgeway HA, Sonnex TS, Kennedy CTC, et al. Hyperpigmentation associated with oral minocycline. Br J Dermatol 1982;107:95-102.
4. Mashimo K, Kato Y, Saito R. Laboratory and clinical investigations on minocycline. Chemotherapy 1970;18:339-46.
5. Gump DW, Ashikaga T, Fink TJ, et al. Dose effects of minocycline: different dosage regimens. Antimicrob Agents Chemother 1977;12:642-6.
6. Beehner MD, Houston GD, Young JD. Oral pigmentation secondary to minocycline pigmentation. J Oral Maxillofac Surg 1986;44:582-4.
7. Tanzi EL. Minocycline-induced hyperpigmentation of the tongue. Arch Fam Med 2000;9:687-8.
8. Caro I. Discoloration of the teeth related to minocycline therapy for acne. J Am Acad Dermatol 1980;3:317-8.
9. Brothers DM, Hidayat AA. Conjunctival pigmentation associated with tetracycline medication. Ophthalmology 1981;88:1212-5.
10. Angeloni VL, Salasche SJ, Ortiz R. Nail, skin and scleral pigmentation induced by minocycline. Cutis 1987;40:229-33.
11. Wolfe ID, Reichmister J. Minocycline pigmentation: skin, tooth, nail, and bone involvement. Cutis 1984;33:457-8.
12. Butler JM, Marks R, Sutherland R. Cutaneous and cardiac valvular pigmentation with minocycline. Clin Exp Dermatol 1985;10:432-7.
13. Anderson RR, Margolis RJ, Watanabe S, et al. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol 1989;93:28-32.
14. Fitzpatrick RE, Goldman MP. Tattoo removal using the alexandrite laser. Arch Dermatol 1994;130:1508-14.
15. Alster TS. Q-switched alexandrite (755 nm) laser treatment of professional and amateur tattoos. J Am Acad Dermatol 1995;33:69-73.
16. Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol Surg 1995;21:592-6.
17. Alster TS. Successful elimination of traumatic tattoos by the Q-switched alexandrite (755-nm) laser. Ann Plast Surg 1995;34:542-5.
18. Goyal S, Arndt KA, Stern RS, et al. Laser treatment of tattoos: a prospective, paired, comparison study of the Q-switched Nd:YAG (1064 nm), frequency-doubled Q-switched Nd:YAG (532 nm) and Q-switched ruby lasers. J Am Acad Dermatol 1997;36:122-5.
19. Goldberg DJ. Laser treatment of pigmented lesions. In Alster TS, Apfelberg DB, eds. Cosmetic Laser Surgery, 2nd ed. New York: Wiley-Liss, 1999:279-88.
20. Kilmer SL. Laser treatment of tattoos. In Alster TS, Apfelberg DB, eds. Cosmetic Laser Surgery, 2nd ed. New York: Wiley-Liss, 1999:289-303.
21. Shah G, Alster TS. Treatment of an amalgam tattoo with a Q-switched alexandrite (755 nm) laser. Dermatol Surg 2002;28:1180-1.
22. Argenyi ZB, Finelli L, Bergfeld WF, et al. Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy, and x-ray energy spectroscopy. J Cutan Pathol 1987;14:176-80.
23. Sato S, Murphy GF, Berhard JD, et al. Ultrastructural and x-ray microanalytical observations of minocycline-related hyperpigmentation of the skin. J Invest Dermatol 1981;77:264-71.
24. Okada N, Sato S, Sasou T. Characterization of pigmented granules in minocycline-induced cutaneous pigmentation. Observations using fluorescence microscopy and high-performance liquid chromatography. Br J Dermatol 1993;129:403-7.
25. Tsao H, Busam K, Barnhill RL, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol 1996;132:1250-1.
26. Wilde JL, English JC III, Finley EM. Minocycline-induced hyperpigmentation: treatment with neodymium:YAG laser. Arch Dermatol 1997;133:1344-6.
27. Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation. Arch Dermatol 1996;132:1251-2.
28. Collins P, Cotterill J. Minocycline-induced pigmentation resolved after treatment with the Q-switched ruby laser. Br J Dermatol 1996;135:317-9.
29. Green D, Friedman KJ. Treatment of minocycline-induced cutaneous pigmentation with the Q-switched alexandrite laser and a review of the literature. J Am Acad Dermatol 2001;44:342-7.
30. Greve B, Schonermark MP, Raulin C. Minocycline-induced hyperpigmentation: treatment with the Q-switched Nd:YAG laser. Lasers Surg Med 1998;22:223-7.
31. Atkin DH, Fitzpatrick RE. Laser treatment of imipramine-induced hyperpigmentation. J Am Acad Dermatol 2000;43:77-80.
32. Karrer S, Hohenleutner U, Szeimies RM, et al. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol 1999;135:251-3.
33. Yun PL, Arndt KA, Anderson RR. Q-switched laser-induced chrysiasis treated with long-pulsed laser. Arch Dermatol 2002;138:1012-4.